PO.4.84 Infections in infants born to mothers with systemic lupus erythematosus and the role of preterm birth by E Svenungsson, J Simard, E Arkema, S Gernaat

PO.2.37 Risk factors for recurrent thrombosis and cause of death in patients with antiphospholipid syndrome; a Swedish cohort study by A Antovic, E Svenungsson, M Magnusson, N Karandyszowska, H Alagündüz, J Oesman, M Bruzelius

S13.2 Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with hHLA-DRB1 *13 and negatively with HLA-DRB1*03 in SLE by J Rönnelid, E Svenungsson, I Gunnarsson, A Zickert, S Elbagir, M Mähler, G Grosso, L Diaz-Gallo

S12.1 Il-16 – a urinary biomarker for proliferative lupus nephritis by V Oke, E Svenungsson, I Gunnarsson, B SUNDELIN, A Zickert, A Larsson, F Faustini, A Häyry

PO.1.20 Prognostic biomarkers of organ damage in patients with newly diagnosed SLE by D Leonard, E Svenungsson, I Gunnarsson, L Rönnblom, C Sjöwall, A Jönsen, AA Bengtsson, H Enocsson, M Eloranta

PO.8.176 Inflammation in blood and placenta in SLE pregnancies by M Saleh, D Leonard, E Svenungsson, I Gunnarsson, L Rönnblom, A Zickert, G Larsson, E Trysberg, B Jacobsson, A Rudin, C Sjöwall, AA Bengtsson, J Andreas, M Stockfelt, A Torell, H Puttonen, H Strevens, M Majcuk Sennström, K Christenson, J Bylund, A Lundell